Non-Invasive Prenatal Testing Market to Reach $10.88 Billion by 2027

Коментари · 482 Виждания

Non-Invasive Prenatal Testing Market 2021: Future Forecast Indicates Impressive Growth Rate, CAGR of 15.2%, Industry Share, Manufacturers Strategy, Opportunities, Challenges, Demands, COVID-19 Analysis and Business Prospect till 2027

Non-Invasive Prenatal Testing Market |2021 Analysis, Key Opportunities Major Players, Impact of COVID-19 and Size, Growth, Share, Regional Analysis With Global Industry Forecast To 2027, The global “Non-Invasive Prenatal Testing Market”, size is projected to reach USD 10.88 billion by the end of 2027. The presence of several large scale companies will have a positive impact on the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Non-Invasive Prenatal Testing (NIPT) Market Size, Share COVID-19 Impact Analysis, By Product (Instruments, and Consumables Reagents), Technology (Next Generation Sequencing, Microarray, PCR, and Rolling Circular Amplification), End User (Hospitals, and Clinical Laboratories) Regional Forecast, 2020-2027,” the market was worth USD 2.95 billion in 2019 and will exhibit a CAGR of 17.8% during the forecast period, 2020-2027.

Non-Invasive Prenatal Testing (NIPT) are used to analyze cell-free fetal DNA that detects whether the fetus will be born with certain genetic abnormalities. This process analyzes small fragments of a DNA that circulate in the blood of a pregnant woman. NIPT is described as non-invasive as only the blood of the pregnant woman is studied and it possesses no risk to the fetus. The massive investments in the development of efficient NIPT tools will bode well for the growth of the overall NIPT market in the foreseeable future. The presence of several large scale companies operating in several countries across the world will have a huge impact on the growth of the overall market in the foreseeable future. The reducing costs of genetic testing will bode well for the growth of the NIPT market in the coming years.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/sample/non-invasive-prenatal-testing-market-100998

Industry Developments:

July 2019: Invitae announced that it will be acquiring Singular Bio, a company specializing in single-molecule cell-free DNA analysis. The collaboration will be aimed at developing non-invasive prenatal test.

What does the Report Include?

The market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers the different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves leading companies and adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.

Non-Invasive Prenatal Testing Highlights of the Report:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

For more information visit : 

https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998

Covid-19 Pandemic to Have a Minimal Impact on NIPT Manufacturers

The Covid-19 pandemic has had an adverse effect on several industries across the world. The efforts taken to curb the spread of the disease have had a damaging impact on several industries across the world. The rapidly rising cases of coronavirus across the world have urged healthcare professionals to focus on tools associated with the treatment of the disease and deviated attention from other concepts such as NIPT. As a result, the Covid-19 pandemic has had a minimal impact on the non-invasive prenatal market in the past few months.

Коментари